FDA Import Refusal 799-2142257-2/11/1 — INDILINA PHARMACEUTICALS
The FDA refused shipment 799-2142257-2/11/1 from INDILINA PHARMACEUTICALS (India) on Dec 19, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Dec 19, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75